PTC Therapeutics | PTCT - Lngresos Netos





Lngresos Netos Cambio Fecha
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Alnylam Pharmaceuticals USD 205.99M 19.57M 2026-03
Amgen USD 1.82B 486M 2026-03
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Biogen USD 319.5M 368.4M 2026-03
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Cytokinetics USD -206.03M 23M 2026-03
Daiichi Sankyo JPY 86.63B 41.32B 2025-12
Enanta Pharmaceuticals USD -22.29M 93.76M 2024-12
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Gilead Sciences USD 2.02B 162M 2026-03
Incyte USD 303.33M 4.05M 2026-03
Ionis Pharmaceuticals USD -93M 136M 2026-03
Ironwood Pharmaceuticals USD 3.19M 457K 2024-12
Karyopharm Therapeutics USD -102.2M 71.42M 2025-12
Novartis USD 3.16B 747M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
PTC Therapeutics USD -2.81M 132.16M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Roche Holding CHF 5.47B 1.76B 2025-12
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
TG Therapeutics USD 19.78M 3.26M 2026-03
Ultragenyx Pharmaceutical USD -185M 56M 2026-03
Vertex Pharmaceuticals USD 1.03B 159.7M 2026-03
Xencor USD -128.92M 122.26M 2026-03